NCT03673501 2026-02-05INTRIGUEDeciphera Pharmaceuticals, LLCPhase 3 Active not recruiting453 enrolled 20 charts
NCT04633122 2025-02-10A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With ImatinibZai Lab (Hong Kong), Ltd.Phase 2 Completed108 enrolled 11 charts
NCT03353753 2022-11-21INVICTUSDeciphera Pharmaceuticals, LLCPhase 3 Completed129 enrolled 19 charts 2 FDA